Showing results (1161-1170 of 1,538) with videos related to

Sort By:
Pageof 154
Aging and Disease|January 31, 2026
Osteoarthritic knee: Advances in Epidemiology, Emerging Etiopathologies and Adipose-Derived Stem Cells-based TherapiesChian-Her Lee, Hsien-Tsung Lu, Ko-Ta Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
The in vitro and in vivo anticancer activities of Antrodia salmonea through inhibition of metastasis and induction of ROS-mediated apoptotic and autophagic cell death in human glioblastoma cellsYi-Pin Lin, You-Cheng Hseu, Varadharajan Thiyagarajan, et al.
Cancer Management and Research|December 13, 2018
HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomyChun-Nan Yeh, Ren-Chin Wu, Chi-Tung Cheng, et al.
Hepatology International|January 4, 2022
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trialWei-Ting Chen, Shi-Ming Lin, Wei-Chen Lee, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Clinical outcomes and cumulative healthcare costs of TAVR vs. SAVR in AsiaElise Chia-Hui Tan, Yung-Tsai Lee, Yu Chen Kuo, et al.
The Prostate|June 18, 2011
Aberrant expression of katanin p60 in prostate cancer bone metastasisXiangcang Ye, Yu-Chen Lee, Michel Choueiri, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 6, 2015
Creatine Kinase (CK)-MB-to-Total-CK Ratio: a Laboratory Indicator for Primary Cancer ScreeningChih-Chun Chang, Ching-Biau Liou, Ming-Jang Su, et al.
World Journal of Surgical Oncology|October 27, 2021
Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatmentYu-Chao Wang, Jin-Chiao Lee, Tsung-Han Wu, et al.
Pageof 154